Korean J Intern Med.
2022 Sep;37(5):920-930. 10.3904/kjim.2022.149.
Vaccination strategies for Korean patients with inflammatory bowel disease
- Affiliations
-
- 1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
- 2Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea
- KMID: 2533134
- DOI: http://doi.org/10.3904/kjim.2022.149
Abstract
- Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine-preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Vaccination and Complementary and Alternative Medicine in Patients with Inflammatory Bowel Disease
- Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea
- Clinical Implication of Sarcopenia in Patients with Inflammatory Bowel Disease
- The Pharmacotherapy of Inflammatory Bowel Disease in Child and Adolescence
- Abdominal Pain over 6 Months
